HHS

The Biden administration plans to elevate the Office of the Assistant Secretary for Preparedness and Response to its own division in a bid to improve the response to current and future public health emergencies, The Washington Post reports.

A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.

After lobbying efforts from lawmakers and science advisors, the new, DARPA-like biomedical research agency will be a part of the National Institutes of Health, but its director will report directly to the secretary of Health and Human Services.

Overbearing restrictions on research into toxins and pathogens such as SARS-CoV-2 could undermine public health and security in the long run.

The glycoprotein researcher and longtime principal deputy director of the National Institutes of Health will take over from Francis Collins on December 20.

The Trump administration suggests deploying the National Guard to ensure timely data sharing into a new, centralized database.

Administration officials have given contradictory statements about how COVID-19 will affect the US, and it is not clear who is leading the infectious disease response effort, critics say.

External researchers funded by US federal grants can continue their experiments under tighter scrutiny.

Information made public by US Senator Chuck Grassley reveals that a handful of allegations have recently been referred to federal investigators.

Health and Human Services plans to review all research involving human fetal tissue.

Appointed by Ronald Reagan, Heckler led the agency from 1983 to 1985, and helped promote research into AIDS.

New documents reveal that Mani Pavuluri had enrolled her sons as controls in a prematurely halted drug trial, a ProPublica investigation finds.

The vaccine shows better-than-expected effectiveness against the most common and most virulent strain of influenza in children under 9 years old.

Funds for the NIH and NSF would stay flat, while some agencies, including the FDA and NASA, would see increases.

Brenda Fitzgerald had drawn criticism for tobacco-related investments, among others.

Both higher education and industry associations were advocating for a later implementation date for the Common Rule, which governs human studies.

Kathy Partin, whose staff had expressed concerns about changes she instituted, was reportedly asked to leave.

The former chief of Eli Lilly USA is picked to replace Tom Price, who stepped down in September amid a controversy over the abuse of taxpayer-funded travel.

Heads of CMS, FDA are among the potential replacements.